Skip to main content
Veterinary Medicines

AQUPHARM RINGER LACTATE SOLUTION FOR INFUSION

Authorised
  • Sodium chloride
  • Sodium lactate
  • Calcium chloride
  • Potassium chloride

Product identification

Medicine name:
AQUPHARM RINGER LACTATE SOLUTION FOR INFUSION
Aqupharm ringerlactaat oplossing voor infusie
Active substance:
  • Sodium chloride
  • Sodium lactate
  • Calcium chloride
  • Potassium chloride
Target species:
  • Cattle
  • Pig
  • Rabbit
  • Cat
  • Horse
  • Sheep
  • Goat
  • Dog
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Sodium chloride
    6.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium lactate
    3.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium chloride
    0.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium chloride
    0.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB01
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 1 bag of 250 ml
  • 1 bag of 500 ml
  • 1 bag of 1000 ml
  • 1 bag of 3000 ml
  • 1 bag of 5000 ml
  • Cardboard box containing 30 bags of 250 ml
  • Cardboard box containing 2 bags of 5000 ml
  • Cardboard box containing 4 bags of 3000 ml
  • Cardboard box containing 10 bags of 1000 ml
  • Cardboard box containing 20 bags of 500 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoire Bioluz
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 117955
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0303/001
Concerned member states:
  • Belgium
  • Finland
  • Hungary
  • Iceland
  • Ireland
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/11/2025